February 01, 2015 3:23 PM ET


Company Overview of Celentyx Ltd.

Company Overview

Celentyx Ltd., a pharmaceutical company, develops treatments for diseases of the human immune system. Its solutions include Immuno-Profiling platform, which enables identification of targets with therapeutic potential and rapid analysis of drug action on human immune cells; and Novel Clinical Indication Profiling, which applies the Immuno-Profiling platform to develop reprofiled drug candidates for diseases of the human immune system. The company’s products also include CX1001, a therapy for B-cell cancers. In addition, its services include rapid analysis/screening of drug action on physiological and pathological human immune tissues and cells; and rapid analysis of drug action on human immu...

Birmingham Research Park

Vincent Drive


Birmingham,  B15 2SQ

United Kingdom

Founded in 2004


44 12 1414 8199


44 12 1414 4509

Key Executives for Celentyx Ltd.

Investor Director and Director
Age: 46
Principal Clinical Scientist
Principal Scientist
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Chugai Pharma Europe Ltd. Europe
DSM Nutritional Products (UK) Ltd Europe
Atmospheric Solutions Ltd. Europe
Daval International Ltd Europe
Pharmacia Ltd. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Celentyx Ltd., please visit www.celentyx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.